154 related articles for article (PubMed ID: 10725065)
1. Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group.
Yocum DE; Allard S; Cohen SB; Emery P; Flipo RM; Goobar J; Jayawardena S; Job-Deslandre C; Jubb RW; Krüger K; Lopes Vaz A; Manger B; Mur E; Nygaard H; Weiner SM; Rainer F; Sack MR; Schiff MH; Schnitzer TJ; Trigg LB; Whatmough I; Schmidt AG
Rheumatology (Oxford); 2000 Feb; 39(2):156-64. PubMed ID: 10725065
[TBL] [Abstract][Full Text] [Related]
2. Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics.
Anderson IF; Helve T; Hannonen P; Leirisalo-Repo M; Gilboe IM; Nissilä M; Keystone EC; Kraag GR; Bjørneboe O; Chalmers A; Dovland H; Mueller E; Richard F; Whatmough I; Schmidt AG; Kovarik JM
J Rheumatol; 1999 Mar; 26(3):556-62. PubMed ID: 10090162
[TBL] [Abstract][Full Text] [Related]
3. Safety and tolerability of conversion from stable Sandimmun maintenance treatment to Sandimmun Neoral in patients with rheumatoid arthritis.
Flipo RM; Emery P; Scott DG; Situnayake RD; Prowse PJ; James DW; Cawley MI; Whatmough I; Schmidt AG
J Rheumatol; 1998 Jul; 25(7):1263-9. PubMed ID: 9676754
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of cyclosporine microemulsion (neoral) versus conventional cyclosporine in liver transplantation: MILTON study. Multicentre International Study in Liver Transplantation of Neoral.
Otto MG; Mayer AD; Clavien PA; Cavallari A; Gunawardena KA; Mueller EA
Transplantation; 1998 Dec; 66(12):1632-40. PubMed ID: 9884251
[TBL] [Abstract][Full Text] [Related]
5. Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
Zachariae H; Abrams B; Bleehen SS; Bräutigam M; Burrows D; Ettelt MJ; Fry L; Happle R; Haustein UF; Ganslandt J; Jung EG; Knop J; Kühne KH; Mellein B; Mørk NJ; Rogers S; Schmidt AG; Schopf RE; Sumner M; Taube KM; Weidinger G; Wurdel C; Zahn E
Dermatology; 1998; 196(2):231-6. PubMed ID: 9568413
[TBL] [Abstract][Full Text] [Related]
6. Neoral--new cyclosporin for old?
Somerville MF; Scott DG
Br J Rheumatol; 1997 Oct; 36(10):1113-5. PubMed ID: 9374930
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients.
Taesch S; Niese D
Transpl Int; 1994; 7 Suppl 1():S263-6. PubMed ID: 11271220
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group.
Koo J
Br J Dermatol; 1998 Jul; 139(1):88-95. PubMed ID: 9764154
[TBL] [Abstract][Full Text] [Related]
9. The use of Neoral in rheumatoid arthritis.
Cranney A; Tugwell P
Rheum Dis Clin North Am; 1998 Aug; 24(3):479-88. PubMed ID: 9710882
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, one-year study of the safety and tolerability of cyclosporine microemulsion compared with conventional cyclosporine in renal transplant patients. International Sandimmun Neoral Study Group.
Frei UA; Neumayer HH; Buchholz B; Niese D; Mueller EA
Transplantation; 1998 Jun; 65(11):1455-60. PubMed ID: 9645802
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
Keown P; Niese D
Kidney Int; 1998 Sep; 54(3):938-44. PubMed ID: 9734620
[TBL] [Abstract][Full Text] [Related]
12. Consistent absorption of cyclosporine from a microemulsion formulation assessed in stable renal transplant recipients over a one-year study period.
Wahlberg J; Wilczek HE; Fauchald P; Nordal KP; Heaf JG; Olgaard K; Hansen JM; Lokkegaard H; Mueller EA; Kovarik JM
Transplantation; 1995 Oct; 60(7):648-52. PubMed ID: 7570970
[TBL] [Abstract][Full Text] [Related]
13. International consensus recommendations on cyclosporin use in rheumatoid arthritis.
Tugwell P
Drugs; 1995; 50 Suppl 1():48-56. PubMed ID: 8714799
[TBL] [Abstract][Full Text] [Related]
14. Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group.
Offermann G; Korn A
Transplant Proc; 1996 Aug; 28(4):2204-6. PubMed ID: 8769201
[No Abstract] [Full Text] [Related]
15. Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. Aa double-blind, single-centre, cross-over pilot study.
Zurbriggen B; Wüthrich B; Cachelin AB; Wili PB; Kägi MK
Dermatology; 1999; 198(1):56-60. PubMed ID: 10026403
[TBL] [Abstract][Full Text] [Related]
16. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
Atakan N; Erdem C
J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic effects of conversion to a new formulation of cyclosporin A in rheumatoid arthritis patients.
Marchesoni A; Fantini F; Battafarano N; Zeni S; Ruiu G; Padula A; Taglione E; Pasero G; Leoni L
Rheumatol Int; 1998; 17(5):197-202. PubMed ID: 9542781
[TBL] [Abstract][Full Text] [Related]
18. Safety aspects of cyclosporin in rheumatoid arthritis.
Dijkmans BA
Drugs; 1995; 50 Suppl 1():41-7. PubMed ID: 8714798
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis.
Erkko P; Granlund H; Nuutinen M; Reitamo S
Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300
[TBL] [Abstract][Full Text] [Related]
20. [Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients].
Sperschneider H; Wagner C; Korn A; Christians U
Med Klin (Munich); 1997 Oct; 92(10):589-96. PubMed ID: 9446006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
